ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A
Williamson CT., Miller R., Pemberton HN., Jones SE., Campbell J., Konde A., Badham N., Rafiq R., Brough R., Gulati A., Ryan CJ., Francis J., Vermulen PB., Reynolds AR., Reaper PM., Pollard JR., Ashworth A., Lord CJ.